Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.08 trillion and total revenue of $110.05 billion.
Market Cap
1.08T
Revenue
110.05B
Profits
-42.02B
PE Ratio
n/a
Profit Margin
-38.18%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.80B | -0.51% | 967,722 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.50B | 0.59% | 248,650 | 14.34B |
| 3 | ARGX | argenx SE | 43.35B | 0.78% | 121,905 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.49B | 0.47% | 1,101,261 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.79B | -1.00% | 103,467 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.58B | 1.31% | 1,595,003 | 606.42M |
| 7 | BNTX | BioNTech SE | 23.88B | 4.95% | 787,756 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 21.76B | 3.36% | 5,069,192 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.22B | -0.11% | 2,755,484 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.85B | 0.52% | 1,313,764 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.77B | 0.79% | 1,367,030 | - |
| 12 | INCY | Incyte Corporation | 18.82B | 1.68% | 682,502 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.00B | -0.38% | 663,143 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.11B | -0.46% | 157,835 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.76B | -0.07% | 518,781 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.40B | -1.11% | 1,252,705 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.00B | 0.46% | 1,214,896 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.34B | 1.24% | 441,392 | 4.27B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.01B | -0.29% | 743,520 | 3.22B |
| 20 | EXEL | Exelixis, Inc. | 10.85B | 1.73% | 1,067,652 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.18B | 0.68% | 96,185 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.85B | 3.14% | 551,798 | 6.23M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.51B | 0.19% | 129,397 | 7.46M |
| 24 | IBRX | ImmunityBio, Inc. | 8.50B | 0.73% | 23,723,134 | 113.29M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.22B | 1.61% | 221,135 | 638.50M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.04B | 0.09% | 943,974 | 1.09B |
| 27 | TECH | Bio-Techne Corporation | 7.99B | 4.61% | 1,141,459 | 1.22B |
| 28 | PCVX | Vaxcyte, Inc. | 7.93B | -0.88% | 355,915 | - |
| 29 | NUVL | Nuvalent, Inc. | 7.79B | -0.40% | 203,905 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.73B | 1.93% | 453,987 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.63B | 1.82% | 1,655,556 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.48B | 2.31% | 129,325 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | 0.01% | 431,679 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.57B | 1.14% | 274,306 | 39.21M |
| 35 | BLTE | Belite Bio, Inc | 6.32B | -2.79% | 144,806 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.19B | 0.30% | 443,348 | 46.02M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.01B | -2.75% | 529,828 | 189.76M |
| 38 | CGON | CG Oncology, Inc. | 5.82B | 4.66% | 946,468 | 4.04M |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 5.78B | 3.48% | 458,793 | 521.31M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.75B | -0.70% | 905,706 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.56B | 0.70% | 677,619 | 1.73B |
| 42 | CELC | Celcuity Inc. | 5.31B | -0.18% | 290,512 | - |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | 0.80% | 671,574 | 7.50M |
| 44 | CAI | Caris Life Sciences, Inc. | 5.23B | -2.89% | 1,290,413 | 812.03M |
| 45 | IMVT | Immunovant, Inc. | 5.10B | 0.16% | 674,004 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 5.09B | 10.74% | 2,328,239 | 616.29M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.80B | -2.73% | 394,691 | - |
| 48 | CRSP | CRISPR Therapeutics AG | 4.80B | 3.30% | 1,290,520 | 3.51M |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.71B | 1.86% | 517,270 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.52B | 0.10% | 1,580,595 | 634.21M |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 4.22B | 1.89% | 122,473 | 268.09M |
| 52 | ERAS | Erasca, Inc. | 4.16B | -0.81% | 3,463,337 | - |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.12B | -1.03% | 1,015,341 | - |
| 54 | TERN | Terns Pharmaceuticals, Inc. | 4.11B | -0.93% | 1,784,505 | - |
| 55 | GPCR | Structure Therapeutics Inc. | 3.95B | -1.57% | 677,077 | - |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.10% | 904,787 | 7.70M |
| 57 | ADMA | ADMA Biologics, Inc. | 3.87B | 2.53% | 1,420,697 | 510.17M |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.87B | 1.63% | 783,810 | 15.00M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.57B | -2.20% | 1,189,130 | 1.07B |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.53B | 3.14% | 550,350 | 761.41M |
| 61 | DNTH | Dianthus Therapeutics, Inc. | 3.50B | 0.96% | 408,364 | 2.04M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.49B | 1.76% | 401,739 | 22.50M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.48B | 0.43% | 486,622 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.45B | -2.46% | 530,255 | 1.03B |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.31B | 3.56% | 685,213 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.28B | 0.63% | 490,430 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.07B | 2.54% | 1,564,224 | - |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -0.11% | 611,085 | 218.71M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 2.94B | 0.03% | 389,145 | 70.85M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.94B | 0.28% | 250,222 | 451.36M |
| 71 | RCUS | Arcus Biosciences, Inc. | 2.86B | 1.56% | 214,849 | 247.00M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | 0.21% | 341,390 | 588.99M |
| 73 | VERA | Vera Therapeutics, Inc. | 2.84B | -0.67% | 378,095 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.83B | 0.31% | 937,283 | 376.07M |
| 75 | TLX | Telix Pharmaceuticals Limited | 2.82B | 5.84% | 170,582 | 803.79M |
| 76 | ALMS | Alumis Inc. | 2.72B | -0.55% | 1,057,585 | 22.12M |
| 77 | BEAM | Beam Therapeutics Inc. | 2.64B | 1.61% | 801,642 | 139.74M |
| 78 | TNGX | Tango Therapeutics, Inc. | 2.63B | 2.91% | 2,230,246 | 62.38M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.55B | -1.39% | 297,704 | 490.73M |
| 80 | MAZE | Maze Therapeutics, Inc. | 2.51B | 1.76% | 548,161 | 2.50M |
| 81 | APLS | Apellis Pharmaceuticals, Inc. | 2.41B | -0.21% | 719,641 | 1.00B |
| 82 | WVE | Wave Life Sciences Ltd. | 2.34B | 0.32% | 1,224,981 | 42.73M |
| 83 | IMNM | Immunome, Inc. | 2.32B | 0.93% | 477,595 | 6.94M |
| 84 | MANE | Veradermics, Incorporated | 2.32B | 9.13% | 346,855 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.29B | -1.36% | 367,236 | - |
| 86 | AAPG | Ascentage Pharma Group International | 2.24B | -1.67% | 2,212 | 54.52M |
| 87 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | -0.26% | 4,289,660 | 158.18M |
| 88 | GLPG | Galapagos NV | 2.18B | 1.25% | 58,160 | 1.31B |
| 89 | NKTR | Nektar Therapeutics | 2.15B | 3.93% | 557,780 | 55.23M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.10B | -0.34% | 586,232 | 673.00M |
| 91 | ZLAB | Zai Lab Limited | 2.10B | -0.42% | 362,215 | 460.16M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.08B | -1.75% | 519,592 | - |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.08B | 1.50% | 821,693 | 276.98M |
| 94 | SNDX | Syndax Pharmaceuticals, Inc. | 2.08B | -1.96% | 539,007 | 172.35M |
| 95 | ORKA | Oruka Therapeutics, Inc. | 2.05B | -1.04% | 398,944 | - |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.02B | 1.11% | 704,083 | - |
| 97 | CLDX | Celldex Therapeutics, Inc. | 1.97B | -1.99% | 182,499 | 1.55M |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.95B | -2.80% | 455,811 | 184.42M |
| 99 | ANAB | AnaptysBio, Inc. | 1.94B | 4.28% | 289,375 | 234.60M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | 0.98% | 350,540 | 283.06M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 1.90B | 1.16% | 1,453,561 | 51.95M |
| 102 | MESO | Mesoblast Limited | 1.87B | -0.68% | 133,467 | 65.38M |
| 103 | RLAY | Relay Therapeutics, Inc. | 1.84B | 1.48% | 862,796 | 15.36M |
| 104 | DFTX | Definium Therapeutics, Inc. | 1.82B | -0.33% | 923,399 | - |
| 105 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 1.62% | 7,628,929 | 74.68M |
| 106 | ZYME | Zymeworks Inc. | 1.79B | 2.67% | 294,622 | 105.97M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 1.68% | 975,929 | 2.20B |
| 108 | NVAX | Novavax, Inc. | 1.76B | 7.44% | 4,577,862 | 1.12B |
| 109 | SLNO | Soleno Therapeutics, Inc. | 1.74B | 0.69% | 501,934 | 190.41M |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 1.42% | 233,585 | 54.03M |
| 111 | VCEL | Vericel Corporation | 1.66B | 1.38% | 263,256 | 276.26M |
| 112 | ELVN | Enliven Therapeutics, Inc. | 1.66B | 1.24% | 453,209 | - |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.64B | 1.97% | 261,384 | 868.45M |
| 114 | INVA | Innoviva, Inc. | 1.64B | -0.14% | 224,100 | 411.33M |
| 115 | SION | Sionna Therapeutics, Inc. | 1.63B | -2.56% | 111,768 | - |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.61B | 1.76% | 671,179 | 83.98M |
| 117 | IOVA | Iovance Biotherapeutics, Inc. | 1.61B | -3.47% | 6,515,299 | 263.50M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 0.75% | 1,351,706 | 67.67M |
| 119 | OCS | Oculis Holding AG | 1.59B | 3.38% | 74,568 | 1.51M |
| 120 | IMCR | Immunocore Holdings plc | 1.57B | 1.14% | 156,001 | 400.02M |
| 121 | GENB | Generate Biomedicines, Inc. | 1.56B | 2.42% | 180,818 | 31.89M |
| 122 | NBTX | Nanobiotix S.A. | 1.56B | -5.50% | 56,339 | 11.93M |
| 123 | NUVB | Nuvation Bio Inc. | 1.52B | -2.89% | 2,007,899 | 62.90M |
| 124 | PHVS | Pharvaris N.V. | 1.47B | -0.11% | 80,121 | - |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.44B | -3.21% | 265,449 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.43B | -0.34% | 1,316,151 | 407.32M |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.43B | -0.27% | 368,592 | - |
| 128 | BHVN | Biohaven Ltd. | 1.42B | -2.18% | 797,772 | - |
| 129 | CAPR | Capricor Therapeutics, Inc. | 1.42B | 1.37% | 566,479 | 11.13M |
| 130 | MBX | MBX Biosciences, Inc. | 1.38B | -2.72% | 264,058 | - |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.38B | -8.57% | 207,902 | - |
| 132 | ATAI | AtaiBeckley Inc. | 1.34B | 1.10% | 2,458,277 | 4.09M |
| 133 | ZBIO | Zenas BioPharma, Inc. | 1.34B | 0.39% | 201,841 | 10.00M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.32B | -1.91% | 1,425,219 | 68.56M |
| 135 | IMTX | Immatics N.V. | 1.32B | 0.51% | 91,624 | 56.67M |
| 136 | RAPP | Rapport Therapeutics, Inc. | 1.32B | -0.36% | 124,914 | - |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | -9.46% | 959,000 | - |
| 138 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | -0.95% | 670,046 | - |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30B | -0.49% | 697,905 | 123.67M |
| 140 | PGEN | Precigen, Inc. | 1.25B | 1.00% | 948,880 | 6.31M |
| 141 | KOD | Kodiak Sciences Inc. | 1.25B | 1.29% | 281,970 | - |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | 0.55% | 672,171 | 6.31M |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.22B | 1.37% | 344,832 | - |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.21B | -1.23% | 249,511 | - |
| 145 | EYPT | EyePoint, Inc. | 1.15B | 2.90% | 498,332 | 31.37M |
| 146 | SEPN | Septerna, Inc. | 1.14B | 0.93% | 97,100 | 45.95M |
| 147 | ABCL | AbCellera Biologics Inc. | 1.08B | 0.28% | 1,219,631 | 75.13M |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.07B | -0.45% | 158,159 | - |
| 149 | GERN | Geron Corporation | 1.06B | 0.30% | 7,640,730 | 183.88M |
| 150 | TVGN | Tevogen Bio Holdings Inc. | 1.06B | -6.20% | 29,490 | - |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.05B | -0.95% | 88,448 | - |
| 152 | SVRA | Savara Inc. | 1.05B | -1.82% | 1,396,005 | - |
| 153 | AKTS | Aktis Oncology, Inc. | 1.02B | -1.62% | 199,399 | 5.56M |
| 154 | PHAR | Pharming Group N.V. | 1.02B | -3.37% | 10,932 | 376.13M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 983.74M | -2.34% | 59,683 | 1.40M |
| 156 | QURE | uniQure N.V. | 979.21M | -1.76% | 1,022,585 | 16.10M |
| 157 | CMPX | Compass Therapeutics, Inc. | 976.08M | 0.18% | 1,693,022 | 850.00K |
| 158 | XERS | Xeris Biopharma Holdings, Inc. | 969.06M | 2.37% | 551,445 | 291.85M |
| 159 | VALN | Valneva SE | 955.31M | 5.78% | 13,930 | 211.09M |
| 160 | CTMX | CytomX Therapeutics, Inc. | 931.77M | -18.89% | 15,821,636 | 76.20M |
| 161 | GHRS | GH Research PLC | 931.68M | -0.60% | 389,199 | - |
| 162 | URGN | UroGen Pharma Ltd. | 908.41M | -0.37% | 846,234 | 109.79M |
| 163 | SGP | SpyGlass Pharma, Inc. | 905.57M | 0.30% | 115,637 | - |
| 164 | FTRE | Fortrea Holdings Inc. | 895.73M | 3.34% | 881,390 | 2.72B |
| 165 | SPRY | ARS Pharmaceuticals, Inc. | 891.69M | 3.22% | 950,266 | 84.28M |
| 166 | EVMN | Evommune, Inc. | 883.53M | 3.81% | 119,254 | 13.00M |
| 167 | ANL | Adlai Nortye Ltd. | 871.22M | -1.38% | 119,384 | -1.35M |
| 168 | SANA | Sana Biotechnology, Inc. | 865.98M | -0.76% | 1,050,898 | - |
| 169 | XNCR | Xencor, Inc. | 861.73M | -2.33% | 526,184 | 125.58M |
| 170 | JANX | Janux Therapeutics, Inc. | 859.55M | 1.80% | 609,415 | 10.00M |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 855.75M | 4.02% | 694,833 | 175.11M |
| 172 | IVA | Inventiva S.A. | 853.00M | 0.82% | 44,985 | 19.93M |
| 173 | ABUS | Arbutus Biopharma Corporation | 840.46M | 0.23% | 690,714 | 14.61M |
| 174 | MNKD | MannKind Corporation | 838.03M | -1.81% | 2,251,011 | 348.97M |
| 175 | OCGN | Ocugen, Inc. | 836.14M | 9.44% | 14,518,807 | 4.41M |
| 176 | KALV | KalVista Pharmaceuticals, Inc. | 836.04M | -1.66% | 250,399 | 1.43M |
| 177 | CGEM | Cullinan Therapeutics, Inc. | 815.29M | -3.99% | 357,355 | - |
| 178 | OMER | Omeros Corporation | 794.09M | 0.54% | 407,431 | - |
| 179 | MPLT | MapLight Therapeutics, Inc. | 785.11M | -4.76% | 109,274 | - |
| 180 | ARVN | Arvinas, Inc. | 770.09M | -1.95% | 571,762 | 262.60M |
| 181 | KURA | Kura Oncology, Inc. | 763.17M | -1.03% | 411,959 | 67.48M |
| 182 | ANRO | Alto Neuroscience, Inc. | 753.59M | -2.88% | 206,855 | - |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 747.31M | 2.55% | 89,441 | - |
| 184 | GYRE | Gyre Therapeutics, Inc. | 746.62M | 2.67% | 64,847 | 116.59M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 738.34M | -0.29% | 66,492 | - |
| 186 | SLS | SELLAS Life Sciences Group, Inc. | 723.61M | -5.22% | 4,681,889 | - |
| 187 | TBPH | Theravance Biopharma, Inc. | 705.87M | - | 191,626 | 80.33M |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 694.84M | 1.86% | 969,186 | 49.80M |
| 189 | EIKN | Eikon Therapeutics, Inc. | 693.43M | 7.49% | 91,283 | - |
| 190 | JBIO | Jade Biosciences, Inc. | 689.93M | -1.82% | 355,413 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 679.63M | 0.27% | 298,745 | - |
| 192 | AGMB | AgomAb Therapeutics NV | 677.44M | -2.90% | 81,997 | - |
| 193 | ANNX | Annexon, Inc. | 671.14M | -1.92% | 1,062,334 | - |
| 194 | PRME | Prime Medicine, Inc. | 669.85M | 1.09% | 936,770 | 4.63M |
| 195 | MDXG | MiMedx Group, Inc. | 652.21M | -0.45% | 308,032 | 418.63M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 646.87M | 1.38% | 178,151 | - |
| 197 | PROK | ProKidney Corp. | 639.27M | -1.16% | 382,659 | 744.00K |
| 198 | LBRX | LB Pharmaceuticals Inc | 624.63M | -6.69% | 249,902 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 613.34M | -0.91% | 149,239 | 27.42M |
| 200 | TECX | Tectonic Therapeutic, Inc. | 609.11M | 0.12% | 96,588 | - |
| 201 | SLDB | Solid Biosciences Inc. | 605.36M | 3.88% | 993,299 | - |
| 202 | REPL | Replimune Group, Inc. | 585.44M | -3.67% | 779,748 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 575.37M | -0.71% | 804,305 | 106.47M |
| 204 | ALLO | Allogene Therapeutics, Inc. | 565.56M | -4.92% | 3,521,316 | 22.00K |
| 205 | DBVT | DBV Technologies S.A. | 540.88M | -2.92% | 143,494 | 5.50M |
| 206 | UPB | Upstream Bio, Inc. | 525.80M | 1.25% | 628,330 | 2.80M |
| 207 | ADCT | ADC Therapeutics SA | 524.69M | -2.13% | 241,205 | 81.36M |
| 208 | CRMD | CorMedix Inc. | 510.67M | -1.22% | 896,176 | 311.71M |
| 209 | RCKT | Rocket Pharmaceuticals, Inc. | 505.39M | -4.41% | 1,085,459 | - |
| 210 | VNDA | Vanda Pharmaceuticals Inc. | 505.37M | -2.95% | 824,975 | 216.11M |
| 211 | YDES | YD Bio Limited | 502.79M | -8.04% | 15,067 | 510.36K |
| 212 | CTNM | Contineum Therapeutics, Inc. | 500.68M | 0.30% | 367,639 | - |
| 213 | ENGN | enGene Holdings Inc. | 497.40M | 2.70% | 448,085 | - |
| 214 | FULC | Fulcrum Therapeutics, Inc. | 496.84M | 0.27% | 1,014,523 | 80.00M |
| 215 | VSTM | Verastem, Inc. | 493.63M | -3.27% | 1,007,105 | 30.91M |
| 216 | PRTA | Prothena Corporation plc | 488.27M | -1.09% | 248,224 | 9.68M |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 486.21M | -0.87% | 134,246 | 294.28M |
| 218 | AVIR | Atea Pharmaceuticals, Inc. | 484.41M | 0.50% | 241,175 | - |
| 219 | TRDA | Entrada Therapeutics, Inc. | 480.85M | -1.41% | 48,667 | 25.42M |
| 220 | NMRA | Neumora Therapeutics, Inc. | 472.03M | -1.57% | 323,923 | - |
| 221 | ACRS | Aclaris Therapeutics, Inc. | 467.31M | 3.61% | 683,749 | 7.83M |
| 222 | RLMD | Relmada Therapeutics, Inc. | 465.67M | 2.75% | 692,920 | - |
| 223 | LXEO | Lexeo Therapeutics, Inc. | 464.20M | -3.20% | 325,630 | - |
| 224 | ALT | Altimmune, Inc. | 460.45M | -2.21% | 1,574,326 | 41.00K |
| 225 | MRVI | Maravai LifeSciences Holdings, Inc. | 460.38M | -0.16% | 447,270 | 185.74M |
| 226 | LYEL | Lyell Immunopharma, Inc. | 459.15M | -6.77% | 107,660 | 36.00K |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.22M | 5.01% | 229,394 | - |
| 228 | RGNX | REGENXBIO Inc. | 453.68M | - | 333,622 | 170.44M |
| 229 | IVVD | Invivyd, Inc. | 453.56M | -3.89% | 2,437,553 | 53.43M |
| 230 | ASMB | Assembly Biosciences, Inc. | 450.63M | -0.87% | 33,223 | 37.19M |
| 231 | ABSI | Absci Corporation | 447.36M | 19.00% | 5,621,390 | 2.82M |
| 232 | FDMT | 4D Molecular Therapeutics, Inc. | 442.75M | 2.36% | 205,613 | 120.00K |
| 233 | AURA | Aura Biosciences, Inc. | 428.65M | 0.15% | 181,460 | - |
| 234 | STTK | Shattuck Labs, Inc. | 425.09M | -1.33% | 214,372 | 1.00M |
| 235 | AVXL | Anavex Life Sciences Corp. | 423.97M | -2.87% | 528,624 | - |
| 236 | ZURA | Zura Bio Limited | 420.70M | 3.03% | 352,545 | - |
| 237 | MNPR | Monopar Therapeutics Inc. | 419.20M | 1.95% | 243,104 | - |
| 238 | IPSC | Century Therapeutics, Inc. | 410.67M | -5.97% | 879,814 | 109.16M |
| 239 | GLSI | Greenwich LifeSciences, Inc. | 410.09M | 5.23% | 636,564 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 406.76M | -1.42% | 55,573 | - |
| 241 | AUTL | Autolus Therapeutics plc | 403.21M | 0.33% | 564,344 | 51.13M |
| 242 | DNA | Ginkgo Bioworks Holdings, Inc. | 399.80M | 0.52% | 260,117 | 170.16M |
| 243 | PRTC | PureTech Health plc | 399.06M | 1.22% | 12 | 6.39M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 397.29M | -0.31% | 456,092 | 14.56M |
| 245 | KYTX | Kyverna Therapeutics, Inc. | 389.79M | -2.09% | 426,588 | - |
| 246 | LENZ | LENZ Therapeutics, Inc. | 389.25M | 5.96% | 498,987 | 17.50M |
| 247 | IMMX | Immix Biopharma, Inc. | 384.13M | 6.22% | 780,760 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 383.06M | 2.25% | 58,621 | 66.98M |
| 249 | NAGE | Niagen Bioscience, Inc. | 382.78M | -0.42% | 1,011,831 | 129.42M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 378.68M | 16.99% | 442,284 | 35.11M |
| 251 | LRMR | Larimar Therapeutics, Inc. | 378.31M | 0.45% | 725,795 | - |
| 252 | CADL | Candel Therapeutics, Inc. | 375.02M | 2.61% | 1,663,099 | - |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 371.83M | -0.56% | 138,310 | - |
| 254 | ARMP | Armata Pharmaceuticals, Inc. | 363.30M | 3.20% | 12,301 | 5.05M |
| 255 | BCYC | Bicycle Therapeutics plc | 355.51M | 0.99% | 732,646 | 72.59M |
| 256 | PEPG | PepGen Inc. | 351.80M | -4.86% | 1,251,758 | - |
| 257 | IRD | Opus Genetics, Inc. | 347.21M | -5.97% | 902,747 | 14.20M |
| 258 | NERV | Minerva Neurosciences, Inc. | 343.60M | 1.28% | 268,981 | - |
| 259 | FBRX | Forte Biosciences, Inc. | 338.85M | -1.49% | 116,743 | - |
| 260 | CLYM | Climb Bio, Inc. | 338.44M | -0.63% | 197,508 | - |
| 261 | NAUT | Nautilus Biotechnology, Inc. | 333.45M | 10.46% | 145,178 | - |
| 262 | ACIU | AC Immune SA | 331.78M | 4.15% | 197,160 | 4.51M |
| 263 | SLN | Silence Therapeutics plc | 330.17M | -4.90% | 524,691 | 559.00K |
| 264 | NBP | NovaBridge Biosciences | 327.43M | -2.07% | 719,315 | - |
| 265 | NGNE | Neurogene Inc. | 325.36M | -2.62% | 73,111 | 925.00K |
| 266 | XOMA | XOMA Royalty Corporation | 323.55M | 2.27% | 62,263 | 47.11M |
| 267 | IMRX | Immuneering Corporation | 316.80M | -1.21% | 1,243,785 | - |
| 268 | PBYI | Puma Biotechnology, Inc. | 309.84M | 0.33% | 120,140 | 228.37M |
| 269 | CBIO | Crescent Biopharma, Inc. | 306.16M | -4.06% | 73,491 | 10.84M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 299.37M | 2.62% | 69,033 | 30.91M |
| 271 | CABA | Cabaletta Bio, Inc. | 297.94M | -3.28% | 1,220,670 | - |
| 272 | PALI | Palisade Bio, Inc. | 295.32M | -0.40% | 2,000,871 | - |
| 273 | TARA | Protara Therapeutics, Inc. | 293.68M | 0.18% | 271,103 | - |
| 274 | AVTX | Avalo Therapeutics, Inc. | 289.78M | -0.25% | 590,990 | 192.00K |
| 275 | ALXO | ALX Oncology Holdings Inc. | 286.91M | 4.81% | 242,553 | - |
| 276 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 285.11M | -5.06% | 129,868 | - |
| 277 | CAMP | Camp4 Therapeutics Corporation | 277.77M | -2.37% | 116,545 | 3.50M |
| 278 | OBIO | Orchestra BioMed Holdings, Inc. | 273.29M | 2.64% | 173,280 | 33.48M |
| 279 | CCCC | C4 Therapeutics, Inc. | 272.24M | 2.20% | 1,047,993 | 35.95M |
| 280 | ABEO | Abeona Therapeutics Inc. | 271.84M | -3.74% | 2,215,962 | 5.82M |
| 281 | TENX | Tenax Therapeutics, Inc. | 264.84M | 10.16% | 516,712 | - |
| 282 | OABI | OmniAb, Inc. | 260.61M | -1.64% | 166,826 | 18.67M |
| 283 | CNTX | Context Therapeutics Inc. | 260.02M | -7.52% | 840,820 | - |
| 284 | PLYX | Polaryx Therapeutics, Inc. | 257.55M | -4.23% | 652,256 | - |
| 285 | CLLS | Cellectis S.A. | 257.41M | -0.86% | 38,384 | 82.55M |
| 286 | CHRS | Coherus Oncology, Inc. | 254.06M | 2.11% | 645,817 | 42.17M |
| 287 | RZLT | Rezolute, Inc. | 248.34M | 4.22% | 2,180,720 | - |
| 288 | ALEC | Alector, Inc. | 248.32M | 1.81% | 304,057 | 21.05M |
| 289 | EDIT | Editas Medicine, Inc. | 244.68M | -1.57% | 560,109 | 40.52M |
| 290 | HELP | Cybin Inc. | 237.42M | 1.17% | 571,534 | - |
| 291 | VYGR | Voyager Therapeutics, Inc. | 233.93M | -9.14% | 1,548,087 | 40.37M |
| 292 | NVCT | Nuvectis Pharma, Inc. | 230.48M | -3.23% | 49,834 | - |
| 293 | ACHV | Achieve Life Sciences, Inc. | 226.78M | 1.43% | 215,389 | - |
| 294 | PLX | Protalix BioTherapeutics, Inc. | 226.39M | -1.92% | 327,072 | 61.84M |
| 295 | ELTX | Elicio Therapeutics, Inc. | 223.24M | -0.21% | 67,206 | - |
| 296 | KROS | Keros Therapeutics, Inc. | 222.71M | 2.40% | 145,081 | 244.06M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 221.53M | 4.58% | 30,347 | 18.97M |
| 298 | MDWD | MediWound Ltd. | 221.21M | -0.55% | 27,058 | 16.96M |
| 299 | SRZN | Surrozen, Inc. | 220.71M | 0.98% | 87,100 | 3.60M |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 218.75M | -0.26% | 108,360 | 38.79M |
| 301 | PRLD | Prelude Therapeutics Incorporated | 218.62M | 3.27% | 92,248 | 12.14M |
| 302 | HUMA | Humacyte, Inc. | 216.30M | 3.12% | 1,921,850 | 1.57M |
| 303 | CGEN | Compugen Ltd. | 212.27M | -1.10% | 127,131 | 72.76M |
| 304 | CNTN | Canton Strategic Holdings, Inc. | 206.41M | -1.07% | 231,907 | - |
| 305 | NTHI | NeOnc Technologies Holdings, Inc. | 205.82M | 1.11% | 11,104 | 59.99K |
| 306 | SABS | SAB Biotherapeutics, Inc. | 204.31M | 1.78% | 135,660 | 114.70K |
| 307 | GALT | Galectin Therapeutics Inc. | 201.80M | -1.57% | 141,007 | - |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 201.62M | 10.91% | 356,834 | 13.11M |
| 309 | MGNX | MacroGenics, Inc. | 198.93M | 0.97% | 266,083 | 149.50M |
| 310 | ZNTL | Zentalis Pharmaceuticals, Inc. | 197.61M | 0.92% | 126,510 | 26.87M |
| 311 | STRO | Sutro Biopharma, Inc. | 195.64M | -2.17% | 79,682 | 105.65M |
| 312 | CBUS | Cibus, Inc. | 192.91M | 2.81% | 292,165 | 3.79M |
| 313 | RNAC | Cartesian Therapeutics, Inc. | 191.66M | -1.36% | 85,858 | 2.80M |
| 314 | PRQR | ProQR Therapeutics N.V. | 188.07M | 1.42% | 226,726 | 19.19M |
| 315 | ADAG | Adagene Inc. | 188.05M | - | 173,092 | 103.20K |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 186.22M | -7.96% | 576,095 | - |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 185.95M | 1.03% | 78,793 | 7.15M |
| 318 | ARCT | Arcturus Therapeutics Holdings Inc. | 185.18M | -1.73% | 358,098 | 82.03M |
| 319 | TNYA | Tenaya Therapeutics, Inc. | 184.82M | -0.63% | 1,467,345 | - |
| 320 | CRBU | Caribou Biosciences, Inc. | 184.58M | 2.14% | 446,028 | 11.16M |
| 321 | NBY | NovaBay Pharmaceuticals, Inc. | 181.88M | -3.97% | 366,523 | 10.30M |
| 322 | MIST | Milestone Pharmaceuticals Inc. | 180.31M | 5.03% | 1,220,478 | - |
| 323 | KRRO | Korro Bio, Inc. | 176.96M | -2.62% | 148,948 | 6.39M |
| 324 | ELDN | Eledon Pharmaceuticals, Inc. | 171.11M | 4.20% | 2,274,354 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 170.80M | 1.26% | 95,916 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 169.75M | 8.97% | 395,739 | 34.26M |
| 327 | PMN | ProMIS Neurosciences, Inc. | 167.70M | -7.24% | 39,408 | - |
| 328 | SGMT | Sagimet Biosciences Inc. | 167.16M | -0.19% | 103,346 | - |
| 329 | NKTX | Nkarta, Inc. | 166.21M | 2.63% | 180,988 | - |
| 330 | EVAX | Evaxion A/S | 160.55M | 0.79% | 23,471 | 7.53M |
| 331 | HRTX | Heron Therapeutics, Inc. | 160.46M | -5.14% | 1,425,746 | 154.90M |
| 332 | VXRT | Vaxart, Inc. | 160.13M | -2.07% | 325,269 | 237.26M |
| 333 | KLRS | Kalaris Therapeutics, Inc. | 159.06M | -3.46% | 33,914 | - |
| 334 | ARTV | Artiva Biotherapeutics, Inc. | 158.56M | 3.80% | 79,409 | 251.00K |
| 335 | MOLN | Molecular Partners AG | 157.13M | -3.23% | 11,317 | 856.30K |
| 336 | IMUX | Immunic, Inc. | 156.56M | 3.45% | 2,033,389 | - |
| 337 | AGEN | Agenus Inc. | 156.28M | 23.71% | 1,320,631 | 114.20M |
| 338 | CNTB | Connect Biopharma Holdings Limited | 153.18M | 1.48% | 10,322 | 762.00K |
| 339 | UNCY | Unicycive Therapeutics, Inc. | 151.08M | 0.29% | 153,845 | - |
| 340 | KPTI | Karyopharm Therapeutics Inc. | 150.42M | -4.09% | 409,105 | 146.07M |
| 341 | IKT | Inhibikase Therapeutics, Inc. | 149.60M | 0.51% | 788,480 | 1.00 |
| 342 | SPRO | Spero Therapeutics, Inc. | 145.36M | -0.39% | 320,700 | 40.55M |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 144.88M | 4.00% | 104,516 | 2.00M |
| 344 | VOR | Vor Biopharma Inc. | 143.15M | -0.07% | 393,425 | - |
| 345 | OVID | Ovid Therapeutics Inc. | 143.14M | 3.08% | 669,597 | 6.61M |
| 346 | VTVT | vTv Therapeutics Inc. | 139.35M | -7.21% | 19,592 | 17.00K |
| 347 | ANTX | AN2 Therapeutics, Inc. | 135.37M | 5.33% | 316,004 | - |
| 348 | MENS | Jyong Biotech Ltd. | 133.99M | -8.84% | 343,315 | - |
| 349 | EQ | Equillium, Inc. | 132.75M | -6.03% | 370,423 | 4.39M |
| 350 | FATE | Fate Therapeutics, Inc. | 131.96M | -2.16% | 986,499 | 6.65M |
| 351 | CDXS | Codexis, Inc. | 131.31M | -3.67% | 1,613,334 | 70.39M |
| 352 | IPHA | Innate Pharma S.A. | 129.33M | -2.13% | 6,399 | 14.84M |
| 353 | CRDF | Cardiff Oncology, Inc. | 129.21M | -0.53% | 464,150 | 593.00K |
| 354 | RANI | Rani Therapeutics Holdings, Inc. | 128.27M | -0.38% | 783,422 | 1.20M |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 128.04M | 2.05% | 519,510 | 70.00M |
| 356 | ACOG | Alpha Cognition Inc. | 126.85M | 0.77% | 3,381 | 7.43M |
| 357 | SGMO | Sangamo Therapeutics, Inc. | 125.01M | 3.02% | 8,214,992 | 32.88M |
| 358 | AARD | Aardvark Therapeutics, Inc. | 117.14M | 0.37% | 172,463 | - |
| 359 | INO | Inovio Pharmaceuticals, Inc. | 117.11M | 3.99% | 470,967 | 65.34K |
| 360 | GOSS | Gossamer Bio, Inc. | 109.57M | 3.82% | 4,359,412 | 44.05M |
| 361 | VRCA | Verrica Pharmaceuticals Inc. | 109.00M | 2.84% | 65,699 | 35.58M |
| 362 | HURA | TuHURA Biosciences, Inc. | 108.67M | 0.95% | 353,236 | - |
| 363 | TTRX | Turn Therapeutics Inc. | 108.31M | 0.77% | 20,813 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 107.35M | -0.24% | 309,894 | - |
| 365 | COYA | Coya Therapeutics, Inc. | 104.15M | -1.33% | 28,490 | 7.95M |
| 366 | CGTX | Cognition Therapeutics, Inc. | 101.52M | 6.48% | 1,064,040 | - |
| 367 | PYXS | Pyxis Oncology, Inc. | 100.87M | -2.99% | 158,463 | 2.82M |
| 368 | SEER | Seer, Inc. | 100.71M | -0.28% | 133,859 | 16.58M |
| 369 | GNLX | Genelux Corporation | 98.93M | -1.14% | 62,181 | 8.00K |
| 370 | ANIX | Anixa Biosciences, Inc. | 97.90M | 2.82% | 24,385 | - |
| 371 | FBIO | Fortress Biotech, Inc. | 97.43M | 1.59% | 202,658 | 62.30M |
| 372 | GANX | Gain Therapeutics, Inc. | 94.94M | 4.37% | 535,891 | - |
| 373 | QTTB | Q32 Bio Inc. | 89.97M | -2.38% | 176,802 | 53.74M |
| 374 | VANI | Vivani Medical, Inc. | 89.73M | 0.82% | 241,114 | - |
| 375 | MCRB | Seres Therapeutics, Inc. | 89.44M | 7.74% | 52,181 | 789.00K |
| 376 | CSBR | Champions Oncology, Inc. | 87.90M | 1.28% | 1,953 | 57.95M |
| 377 | SPRB | Spruce Biosciences, Inc. | 87.12M | 4.18% | 29,006 | 697.00K |
| 378 | BMEA | Biomea Fusion, Inc. | 86.97M | -1.60% | 1,061,115 | - |
| 379 | ATYR | aTyr Pharma, Inc. | 86.73M | -1.12% | 493,023 | 190.00K |
| 380 | IBIO | iBio, Inc. | 85.32M | 3.35% | 200,056 | 300.00K |
| 381 | PMVP | PMV Pharmaceuticals, Inc. | 84.79M | 1.92% | 106,564 | - |
| 382 | PLRX | Pliant Therapeutics, Inc. | 83.89M | 3.44% | 356,163 | - |
| 383 | KZIA | Kazia Therapeutics Limited | 82.45M | -6.64% | 45,760 | 1.20M |
| 384 | PYPD | PolyPid Ltd. | 81.92M | 2.27% | 137,261 | - |
| 385 | ALDX | Aldeyra Therapeutics, Inc. | 78.84M | -69.03% | 47,354,211 | - |
| 386 | CING | Cingulate Inc. | 78.38M | 8.21% | 979,127 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 77.65M | - | 222 | 7.41M |
| 388 | ANVS | Annovis Bio, Inc. | 77.39M | -3.55% | 285,185 | - |
| 389 | NRXS | NeurAxis, Inc. | 76.17M | 1.42% | 362,342 | 3.36M |
| 390 | MNOV | MediciNova, Inc. | 74.08M | 3.79% | 77,153 | 409.66K |
| 391 | BYSI | BeyondSpring Inc. | 72.80M | 3.74% | 12,317 | 1.88M |
| 392 | XBIT | XBiotech Inc. | 68.90M | -1.74% | 61,827 | - |
| 393 | ACET | Adicet Bio, Inc. | 68.42M | -0.56% | 37,695 | - |
| 394 | GRCE | Grace Therapeutics, Inc. | 68.40M | - | 528,631 | - |
| 395 | IMA | ImageneBio, Inc. | 64.99M | -1.61% | 7,852 | 800.00K |
| 396 | ENTX | Entera Bio Ltd. | 64.89M | 4.81% | 24,677 | 124.00K |
| 397 | GUTS | Fractyl Health, Inc. | 64.42M | 2.17% | 1,237,453 | 3.00K |
| 398 | ACTU | Actuate Therapeutics, Inc. | 64.27M | 3.17% | 51,529 | - |
| 399 | COEP | Coeptis Therapeutics Holdings, Inc. | 63.87M | -0.33% | 19,400 | 501.00K |
| 400 | TCRX | TScan Therapeutics, Inc. | 63.16M | 4.72% | 885,784 | 10.33M |
| 401 | EXOZ | eXoZymes, Inc. | 62.90M | 2.74% | 840 | -700.00 |
| 402 | IFRX | InflaRx N.V. | 62.08M | 0.69% | 90,109 | 73.73K |
| 403 | ATHE | Alterity Therapeutics Limited | 61.81M | -5.54% | 15,039 | 4.43M |
| 404 | HYFT | MindWalk Holdings Corp. | 61.09M | 2.50% | 88,664 | 20.70M |
| 405 | MREO | Mereo BioPharma Group plc | 60.01M | -5.47% | 1,344,363 | 500.00K |
| 406 | IMMP | Immutep Limited | 59.51M | -12.87% | 3,460,557 | 5.28M |
| 407 | RADX | Radiopharm Theranostics Limited | 59.01M | 2.36% | 11,747 | 10.86M |
| 408 | TIL | Instil Bio, Inc. | 58.60M | 5.24% | 15,913 | - |
| 409 | LPCN | Lipocine Inc. | 56.65M | 6.45% | 87,017 | 1.98M |
| 410 | EDSA | Edesa Biotech, Inc. | 56.60M | 32.42% | 8,607,986 | - |
| 411 | OKUR | OnKure Therapeutics, Inc. | 56.13M | 5.26% | 111,196 | - |
| 412 | MAIA | MAIA Biotechnology, Inc. | 55.55M | -2.60% | 460,373 | - |
| 413 | ICCC | ImmuCell Corporation | 55.18M | -4.46% | 42,542 | 27.64M |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 54.79M | -6.25% | 776,257 | 242.00K |
| 415 | MGX | Metagenomi Therapeutics, Inc. | 54.74M | -1.69% | 157,321 | 25.21M |
| 416 | OSTX | OS Therapies Incorporated | 53.53M | 1.33% | 173,497 | - |
| 417 | ACRV | Acrivon Therapeutics, Inc. | 52.38M | -2.35% | 759,801 | - |
| 418 | DCOY | Decoy Therapeutics Inc. | 51.49M | 0.75% | 9,793 | - |
| 419 | RLYB | Rallybio Corporation | 50.73M | 1.91% | 156,108 | 858.00K |
| 420 | KZR | Kezar Life Sciences, Inc. | 50.53M | - | 1,185 | - |
| 421 | GOVX | GeoVax Labs, Inc. | 49.91M | -2.91% | 32,904 | 3.35M |
| 422 | NTRB | Nutriband Inc. | 47.66M | 4.21% | 9,776 | 2.28M |
| 423 | IBO | Impact BioMedical Inc. | 47.18M | -0.27% | 187,148 | 32.00K |
| 424 | ESLA | Estrella Immunopharma, Inc. | 46.45M | 5.13% | 15,475 | - |
| 425 | ALGS | Aligos Therapeutics, Inc. | 46.16M | -3.37% | 13,506 | 2.19M |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | -0.75% | 28,147 | - |
| 427 | LSTA | Lisata Therapeutics, Inc. | 45.52M | - | 14,901 | 170.00K |
| 428 | INKT | MiNK Therapeutics, Inc. | 45.30M | 5.81% | 72,452 | - |
| 429 | ATOS | Atossa Therapeutics, Inc. | 44.78M | 4.63% | 39,960 | - |
| 430 | LITS | Lite Strategy, Inc. | 44.73M | -1.60% | 105,065 | - |
| 431 | PSTV | Plus Therapeutics, Inc. | 44.16M | -1.27% | 2,324,340 | 5.21M |
| 432 | NXTC | NextCure, Inc. | 43.42M | 1.96% | 5,361 | - |
| 433 | CMMB | Chemomab Therapeutics Ltd. | 42.42M | -4.21% | 75,395 | - |
| 434 | APLM | Apollomics, Inc. | 41.87M | -0.05% | 908 | 6.93M |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 41.75M | 6.05% | 340,340 | 1.14M |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 41.46M | -13.63% | 250,824 | 120.77M |
| 437 | PTN | Palatin Technologies, Inc. | 41.01M | 0.53% | 10,198 | 8.96M |
| 438 | CRVO | CervoMed Inc. | 40.83M | 2.32% | 61,667 | 4.01M |
| 439 | LONA | LeonaBio, Inc. | 39.16M | 17.93% | 109,879 | - |
| 440 | VERU | Veru Inc. | 39.00M | 2.53% | 28,509 | 16.89M |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 38.43M | 1.87% | 53,153 | - |
| 442 | RNTX | Rein Therapeutics Inc. | 37.72M | 5.51% | 156,598 | - |
| 443 | CELU | Celularity Inc. | 37.49M | 4.84% | 37,014 | 40.58M |
| 444 | RNXT | RenovoRx, Inc. | 36.10M | 1.22% | 459,303 | 928.00K |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 35.88M | 3.60% | 51,916 | 90.00K |
| 446 | JSPR | Jasper Therapeutics, Inc. | 34.98M | 0.81% | 130,080 | - |
| 447 | INMB | INmune Bio Inc. | 34.83M | -2.96% | 65,387 | 50.00K |
| 448 | PDSB | PDS Biotechnology Corporation | 34.80M | 12.28% | 1,084,997 | - |
| 449 | TVRD | Tvardi Therapeutics, Inc. | 33.96M | -6.94% | 22,065 | - |
| 450 | ABVC | ABVC BioPharma, Inc. | 33.84M | 0.76% | 25,803 | 797.92K |
| 451 | PLUR | Pluri Inc. | 33.07M | 0.12% | 8,740 | 1.34M |
| 452 | TLSA | Tiziana Life Sciences Ltd | 31.73M | -0.37% | 83,330 | - |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.52M | 5.29% | 336,591 | - |
| 454 | OTLK | Outlook Therapeutics, Inc. | 31.41M | 7.45% | 1,513,689 | 205.70K |
| 455 | CVM | CEL-SCI Corporation | 31.38M | 5.10% | 18,202 | - |
| 456 | TPST | Tempest Therapeutics, Inc. | 30.64M | 2.83% | 19,911 | - |
| 457 | HYPD | Hyperion DeFi, Inc. | 30.61M | -1.82% | 318,474 | 345.32K |
| 458 | DYAI | Dyadic International, Inc. | 29.67M | 1.28% | 118,621 | 3.34M |
| 459 | KYNB | Kyntra Bio, Inc. | 29.66M | 4.71% | 64,910 | 6.44M |
| 460 | XCUR | Exicure, Inc. | 28.68M | -1.79% | 27,216 | 500.00K |
| 461 | BRNS | Barinthus Biotherapeutics plc | 27.77M | -0.01% | 646 | 14.97M |
| 462 | XLO | Xilio Therapeutics, Inc. | 27.75M | -3.39% | 43,037 | 31.80M |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 27.38M | 1.07% | 144,270 | - |
| 464 | LTRN | Lantern Pharma Inc. | 26.51M | -1.66% | 26,031 | - |
| 465 | ENLV | Enlivex Ltd. | 26.48M | 2.78% | 125,135 | - |
| 466 | IGC | IGC Pharma, Inc. | 26.37M | 1.54% | 307,894 | 1.11M |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 26.15M | 4.73% | 530,173 | 789.00K |
| 468 | SNTI | Senti Biosciences, Inc. | 25.72M | -0.31% | 46,654 | - |
| 469 | BOLD | Boundless Bio, Inc. | 25.54M | 1.79% | 17,035 | - |
| 470 | CUE | Cue Biopharma, Inc. | 25.50M | -16.18% | 7,999,114 | 27.47M |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 24.64M | -0.44% | 27,444 | 14.99M |
| 472 | NNVC | NanoViricides, Inc. | 24.40M | -0.88% | 90,842 | - |
| 473 | PASG | Passage Bio, Inc. | 23.58M | -3.80% | 12,097 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 23.01M | -2.13% | 41,474 | 4.69M |
| 475 | SKYE | Skye Bioscience, Inc. | 22.50M | -5.83% | 112,900 | - |
| 476 | DARE | Daré Bioscience, Inc. | 20.72M | -1.36% | 23,415 | -57.13K |
| 477 | LGVN | Longeveron Inc. | 20.69M | 9.24% | 3,281,551 | 1.44M |
| 478 | VYNE | VYNE Therapeutics Inc. | 20.17M | 0.21% | 107,786 | 570.00K |
| 479 | KTTA | Pasithea Therapeutics Corp. | 19.83M | 3.92% | 65,480 | - |
| 480 | ALLR | Allarity Therapeutics, Inc. | 19.76M | -2.34% | 76,928 | - |
| 481 | INAB | IN8bio, Inc. | 19.35M | -4.61% | 46,683 | - |
| 482 | LEXX | Lexaria Bioscience Corp. | 18.67M | 5.99% | 89,168 | 522.00K |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 18.59M | -5.63% | 621,757 | 3.94M |
| 484 | FBLG | FibroBiologics, Inc. | 18.53M | -2.87% | 885,701 | - |
| 485 | TRAW | Traws Pharma, Inc. | 17.26M | 2.37% | 59,306 | 2.85M |
| 486 | LIXT | Lixte Biotechnology Holdings, Inc. | 17.11M | -2.28% | 21,170 | - |
| 487 | INTS | Intensity Therapeutics, Inc. | 16.32M | 1.90% | 20,025 | - |
| 488 | GNTA | Genenta Science S.p.A. | 15.80M | -2.99% | 41,572 | - |
| 489 | AEON | AEON Biopharma, Inc. | 15.73M | 0.02% | 21,371 | - |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 15.67M | 0.33% | 27,180 | - |
| 491 | HOTH | Hoth Therapeutics, Inc. | 15.59M | -3.37% | 339,789 | - |
| 492 | SER | Serina Therapeutics, Inc. | 14.93M | -4.11% | 47,050 | 116.00K |
| 493 | COCP | Cocrystal Pharma, Inc. | 14.82M | -0.46% | 25,146 | - |
| 494 | PHIO | Phio Pharmaceuticals Corp. | 14.46M | -1.19% | 233,199 | - |
| 495 | LNAI | Lunai Bioworks Inc. | 14.17M | 176.55% | 527,842,180 | - |
| 496 | CLRB | Cellectar Biosciences, Inc. | 14.16M | 2.14% | 19,429 | - |
| 497 | ACXP | Acurx Pharmaceuticals, Inc. | 14.05M | 2.29% | 4,853,666 | - |
| 498 | BCDA | BioCardia, Inc. | 13.80M | 2.36% | 205,998 | 3.00K |
| 499 | CALC | CalciMedica, Inc. | 13.64M | -3.40% | 167,693 | - |
| 500 | PLRZ | Polyrizon Ltd. | 13.57M | -2.46% | 30,741 | - |
| 501 | JUNS | Jupiter Neurosciences, Inc. | 13.46M | -7.48% | 38,532 | - |
| 502 | GTBP | GT Biopharma, Inc. | 13.33M | -0.56% | 218,601 | - |
| 503 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.17M | -0.61% | 3,282 | - |
| 504 | IOBT | IO Biotech, Inc. | 13.02M | 2.84% | 1,783,860 | - |
| 505 | SNGX | Soligenix, Inc. | 12.71M | 2.44% | 85,937 | 2.34K |
| 506 | KAPA | Kairos Pharma, Ltd. | 12.39M | -2.47% | 44,740 | - |
| 507 | PPBT | Purple Biotech Ltd | 12.38M | -0.12% | 6,562 | - |
| 508 | NCEL | NewcelX Ltd. | 12.03M | -1.12% | 12,670 | - |
| 509 | GDTC | CytoMed Therapeutics Limited | 11.77M | -2.86% | 5,453 | 573.19K |
| 510 | BLRX | BioLineRx Ltd. | 11.64M | 3.80% | 10,484 | 12.74M |
| 511 | OSRH | OSR Holdings, Inc. | 11.42M | -1.13% | 145,433 | -90.52K |
| 512 | CRIS | Curis, Inc. | 11.25M | 1.42% | 84,260 | 11.65M |
| 513 | BIVI | BioVie Inc. | 10.49M | -2.80% | 138,387 | - |
| 514 | BCAB | BioAtla, Inc. | 10.27M | -4.17% | 2,307,010 | 11.00M |
| 515 | ARTL | Artelo Biosciences, Inc. | 9.50M | 7.71% | 18,833 | - |
| 516 | IMNN | Imunon, Inc. | 9.40M | 1.32% | 17,327 | - |
| 517 | ITRM | Iterum Therapeutics plc | 9.11M | 0.94% | 277,188 | 390.00K |
| 518 | QNTM | Quantum BioPharma Ltd. | 9.11M | -2.12% | 61,423 | - |
| 519 | ICU | SeaStar Medical Holding Corporation | 8.90M | 2.92% | 21,879 | 881.00K |
| 520 | APRE | Aprea Therapeutics, Inc. | 8.85M | 2.20% | 44,984 | 285.76K |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 8.65M | -0.88% | 20,448 | 7.70M |
| 522 | TOVX | Theriva Biologics, Inc. | 8.46M | -4.41% | 3,192,997 | - |
| 523 | RNAZ | TransCode Therapeutics, Inc. | 8.45M | -1.50% | 3,357 | - |
| 524 | ERNA | Ernexa Therapeutics Inc. | 8.40M | -4.54% | 563,968 | 1,000.00 |
| 525 | ADXN | Addex Therapeutics Ltd | 8.40M | - | 217 | 198.82K |
| 526 | AKTX | Akari Therapeutics, Plc | 8.22M | 11.11% | 726,526 | - |
| 527 | PHGE | BiomX Inc. | 7.86M | -10.04% | 62,237 | - |
| 528 | PULM | Pulmatrix, Inc. | 7.78M | -0.47% | 16,965 | 3.00K |
| 529 | EVGN | Evogene Ltd. | 7.67M | 11.26% | 239,494 | 3.85M |
| 530 | CLGN | CollPlant Biotechnologies Ltd. | 7.67M | -1.61% | 14,039 | 2.48M |
| 531 | KPRX | Kiora Pharmaceuticals, Inc. | 7.58M | -1.44% | 11,582 | 20.00K |
| 532 | DWTX | Dogwood Therapeutics, Inc. | 7.52M | 7.19% | 20,115 | - |
| 533 | GRDX | GridAI Technologies Corp. | 7.46M | -6.72% | 52,143 | - |
| 534 | PCSA | Processa Pharmaceuticals, Inc. | 7.30M | 3.21% | 11,192 | - |
| 535 | SPRC | SciSparc Ltd. | 7.28M | 3.94% | 14,324 | 1.31M |
| 536 | MLEC | Moolec Science SA | 7.24M | 0.25% | 3,195 | 7.83M |
| 537 | XBIO | Xenetic Biosciences, Inc. | 7.17M | -7.40% | 38,670 | 2.98M |
| 538 | TCRT | Alaunos Therapeutics, Inc. | 7.12M | -2.15% | 8,402 | 6.00K |
| 539 | PMCB | PharmaCyte Biotech, Inc. | 7.09M | -0.14% | 73,408 | - |
| 540 | ALZN | Alzamend Neuro, Inc. | 7.04M | -11.89% | 370,147 | - |
| 541 | MBRX | Moleculin Biotech, Inc. | 6.94M | 5.85% | 87,256 | - |
| 542 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.76M | -5.19% | 286,561 | 14.83K |
| 543 | LIMN | Liminatus Pharma, Inc. | 6.49M | 1.65% | 2,618,256 | - |
| 544 | MBIO | Mustang Bio, Inc. | 6.47M | -4.69% | 30,403 | - |
| 545 | IMRN | Immuron Limited | 6.18M | -4.30% | 36,806 | 4.99M |
| 546 | CYCN | Cyclerion Therapeutics, Inc. | 5.89M | 1.01% | 32,633 | 2.86M |
| 547 | PBM | Psyence Biomedical Ltd. | 5.73M | - | 9,665 | - |
| 548 | QNCX | Quince Therapeutics, Inc. | 5.43M | -6.25% | 9,268,478 | - |
| 549 | XTLB | XTL Biopharmaceuticals Ltd. | 5.36M | -2.34% | 10,356 | 968.00K |
| 550 | BDRX | Biodexa Pharmaceuticals Plc | 5.02M | 0.38% | 85,361 | 104.90K |
| 551 | APM | Aptorum Group Limited | 4.99M | 0.04% | 5,351 | - |
| 552 | SLXN | Silexion Therapeutics Corp | 4.96M | 0.96% | 4,206 | - |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 4.93M | 0.53% | 11,332 | 6.00K |
| 554 | VIVS | VivoSim Labs, Inc. | 4.82M | 2.78% | 26,085 | 142.00K |
| 555 | GNPX | Genprex, Inc. | 4.73M | -1.45% | 196,938 | - |
| 556 | BGMS | Bio Green Med Solution, Inc. | 4.51M | -0.08% | 5,491 | 81.00K |
| 557 | REVB | Revelation Biosciences, Inc. | 4.50M | -2.42% | 43,135 | - |
| 558 | SILO | Silo Pharma, Inc. | 4.33M | -5.25% | 53,554 | 72.10K |
| 559 | ASBP | Aspire Biopharma Holdings, Inc. | 4.32M | -11.90% | 298,672 | 1.94K |
| 560 | APVO | Aptevo Therapeutics Inc. | 4.25M | -2.99% | 22,474 | - |
| 561 | MTNB | Matinas BioPharma Holdings, Inc. | 3.84M | -2.30% | 11,644 | - |
| 562 | GRI | GRI Bio, Inc. | 3.73M | 1.33% | 24,934 | - |
| 563 | NCNA | NuCana plc | 3.63M | - | 45,881 | - |
| 564 | GLMD | Galmed Pharmaceuticals Ltd. | 3.43M | 1.20% | 8,286 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 3.41M | 11.43% | 13,733 | - |
| 566 | OGEN | Oragenics, Inc. | 3.32M | -4.41% | 156,159 | - |
| 567 | HCWB | HCW Biologics Inc. | 2.88M | -6.21% | 16,565,160 | 422.03K |
| 568 | ENVB | Enveric Biosciences, Inc. | 2.82M | 2.01% | 19,144 | - |
| 569 | ADIL | Adial Pharmaceuticals, Inc. | 2.74M | 3.78% | 11,347 | - |
| 570 | XRTX | XORTX Therapeutics Inc. | 2.59M | -3.54% | 33,422 | - |
| 571 | AZTR | Azitra, Inc. | 2.53M | -3.64% | 253,860 | 7.50K |
| 572 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.43M | 2.22% | 261,241 | 1.36M |
| 573 | BRTX | BioRestorative Therapies, Inc. | 2.29M | -10.28% | 1,255,792 | 383.40K |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.22M | -4.48% | 212,667 | - |
| 575 | BBLG | Bone Biologics Corporation | 2.19M | - | 11,646 | - |
| 576 | SCNI | Scinai Immunotherapeutics Ltd. | 2.18M | -1.41% | 5,335 | 1.15M |
| 577 | KALA | KALA BIO, Inc. | 1.97M | -9.91% | 5,726,438 | - |
| 578 | ONCO | Onconetix, Inc. | 1.90M | 2.66% | 70,787 | 815.37K |
| 579 | PPCB | Propanc Biopharma, Inc. | 1.81M | -11.63% | 2,347,742 | - |
| 580 | JAGX | Jaguar Health, Inc. | 1.76M | -6.81% | 331,612 | 11.79M |
| 581 | ENSC | Ensysce Biosciences, Inc. | 1.63M | 7.03% | 251,037 | 4.49M |
| 582 | CNSP | CNS Pharmaceuticals, Inc. | 1.49M | -1.63% | 41,769 | - |
| 583 | DRMA | Dermata Therapeutics, Inc. | 1.45M | 2.50% | 39,070 | - |
| 584 | CMND | Clearmind Medicine Inc. | 1.11M | 0.03% | 90,229 | - |
| 585 | OKYO | OKYO Pharma Limited | 921.14K | -4.76% | 152,066 | - |
| 586 | VRAX | Virax Biolabs Group Limited | 873.17K | 7.89% | 139,301 | 2.99K |
| 587 | ADTX | Aditxt, Inc. | 833.29K | -8.06% | 185,240 | 5.95K |
| 588 | CDT | CDT Equity Inc. | 795.23K | 6.98% | 84,272 | - |
| 589 | LYRA | Lyra Therapeutics, Inc. | 674.46K | -23.23% | - | 600.00K |
| 590 | ELAB | PMGC Holdings Inc. | 368.97K | -9.19% | 27,815 | 285.95K |
| 591 | MTVA | MetaVia Inc. | 319.91K | -1.29% | 71,043 | - |
| 592 | CANF | Can-Fite BioPharma Ltd. | 19.63K | -3.63% | 36,020 | 560.00K |